PharmaCyte Biotech, Inc. (PMCB)
NASDAQ
Closed
Sep 21, 2026
Day's Range
0.440152 wk Range
0.3339Profile - PMCB - PharmaCyte Biotech, Inc.
Profile
Mic Code
XNCM
Sector
Healthcare
Industry
Biotechnology
Employees
2
PharmaCyte Biotech, Inc. is a clinical-stage biotechnology company focused on developing cellular therapies for cancer and diabetes. Its core platform is Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology designed to support therapies for difficult-to-treat conditions, including inoperable pancreatic cancer and other solid tumors. The company’s work centers on applying this platform to create treatment candidates that protect and deliver living cells in a controlled way. PharmaCyte Biotech is also active in related areas such as malignant ascites, reflecting a broader focus on oncology and metabolic disease applications. Headquartered in Las Vegas, Nevada, PharmaCyte Biotech operates as a research-driven company in the health technology sector, with its current business concentrated on advancing product development and commercialization efforts in specialized cellular medicine.
Profile Details
Type
Common Stock
Address
3960 Howard Hughes Parkway
City
Las Vegas
State
NV
Zip
89169
Country
United States
Phone
917 595 2850
Key Executives - PMCB - PharmaCyte Biotech, Inc.
Key executives
Cross Listings - PMCB - PharmaCyte Biotech, Inc.
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
